BLS Pharmaceuticals LimitedASX: BLS

Letter to Shareholders re Annual General Meeting

· Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · · 2 pages · English

Release

Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000, Australia hello@breathelifesciences.com +61 2 9078 8180 23 October 2026 ANNUAL GENERAL MEETING NOTICE AND PROXY FORM Dear Shareholder, The Annual General Meeting (Meeting) of shareholders of Bioxyne Limited (ACN 084 464 193) (Company) will be...

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

Later from BLS Pharmaceuticals

All BLS Pharmaceuticals news releases